Inflammatory mediators do not stimulate CGRP release if prostaglandin synthesis is blocked by S(+)-flurbiprofen in isolated rat skin

Inflammation Research

Volumn 52, Issue 12, 2003, Pages 519-523

  Averbeck, B ^a   Peisler, M ^b   Izydorczyk, I ^c   Reeh, P W ^c  

^a SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

^b KLINIKUM COBURG   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Enantiomer; Neurogenic inflammation; Neuropeptide release; Nociception; Nonsteroidal antiinflammatory drugs; PGE2 release

Indexed keywords

BRADYKININ; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; FLURBIPROFEN; HISTAMINE; PROSTAGLANDIN; PROSTAGLANDIN E2; SEROTONIN;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENANTIOMER; MALE; NONHUMAN; PROSTAGLANDIN RELEASE; PROSTAGLANDIN SYNTHESIS; PROTEIN SECRETION; RAT; SKIN CULTURE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BRADYKININ; CALCITONIN GENE-RELATED PEPTIDE; DINOPROSTONE; FLURBIPROFEN; HISTAMINE; INFLAMMATION MEDIATORS; MALE; POTASSIUM CHLORIDE; RATS; RATS, WISTAR; SEROTONIN; SKIN;

EID: 0347986561     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00011-003-1209-1     Document Type: Article

References (27)

1. Abbott FV and Hellemans KG. Phenacetin, acetaminophen and dipyrone: analgesic and rewarding effects, Behav. Brain Res. 2000; 112: 177-86
2. 2 from isolated rat skin, Neuropharmacology, 2001; 40: 416-23.
3. Bretag AH. Synthetic interstitial fluid for isolated mammalian tissue, Life Sci. 1969; 8: 319-29.
4. Brune K, Beck WS, Geisslinger G, Menzel-Soglowek S, Peskar BM and Peskar BA. Aspirin-like drugs may block pain independently of prostaglandin synthesis inhibition, Experientia 1991; 47: 257-61.
5. Brune K, Reinke M, Lanz R, and Peskar BA. Monoclonal antibodies against E- and F-type prostaglandins. High specificity and sensitivity in conventional radioimmunoassays, FEBS Letters 1985; 186: 46-50.
6. Buritova J and Besson JM. Pripheral and/ or central effects of racemic S(+)- and R(-)-flurbiprofen on inflammatory nociceptive processes: a c-Fos protein study in the rat spinal cord, Br. J. Pharmacol. 1998; 125: 87-101
7. Chandrasekharan NV, Dai H, Roos KL, Evanson NK, Tomsik J, Elton TS et al. From the Cover: COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/ antipyretic drugs: Cloning, structure, and expression, Proc. Natl. Sci. USA 2002; 99: 13926-31.
8. Ferreira SH. Prostaglandins, aspirin-like drugs and analgesia, Nature 1972; 240: 200-3.
9. Geisslinger G, Ferreira S, Menzel S, Schlott D and Brune K. Antinociceptive actions of R-flurbiprofen - a non-COX inhibiting 2-arylpropionic acid - in rats, Life Sci. 1994; 54: 173-77
10. Geisslinger G, Muth-Selbach U, Coste O, Vetter G, Schrodter A, Schaible HG et al. Inhibition of noxious stimulus-induced spinal prostaglandin E2 release by flurbiprofen enantiomers: a microdialysis study, J. Neurochem. 2000; 74: 2094-100.
11. Hingtgen CM, Waite KJ, Vasko MR. Prostaglandins facilitate peptide release from rat sensory neurons by activating the adenosine 3′,5′-cyclic monophosphate transduction cascade, J. Neurosci. 1995; 15: 5411-19.
12. Holzer P. Local effector functions of capsaicin sensitive sensory nerve endings: involvement of tachykinins, CGRP and other neuropeptides, Neuroscience 1988; 24: 739-68.
13. Hoogerwerf WA, Zou L, Shenoy M, Sun D, Micci MA, Lee-Hellmich H et al. The Proteinase-activated receptor 2 is involved in nociception, J. Neurosci. 2001; 15: 9036-42.
14. 2 but not substance P release induced by antidromic nerve stimulation from rat skin in vitro, Neuroscience 1999; 89: 303-10.
15. Kress M, Izydorczyk I, Kuhn A. N- and L- but not P/Q-type calcium channels contribute to neuropeptide release from rat skin in vitro, NeuroReport 2001; 12: 867-70.
16. Kress M and Reeh PW. Chemical excitation and sensitization in nociceptors. In: Belmonte C. and Cervero F. (Eds.), Neurobiology of Nociceptors, Oxford University Press, Oxford, 1996; pp. 258-97.
17. Lembeck F and Holzer P. Substance P as neurogenic mediator of antidromic vasodilatation and neurogenic plasma extravasation, Naunyn-Schmiedeberg's Arch. Pharmacol 1979; 310: 175-83.
18. Malmberg AB and Yaksh TL. Antinociception produced by spinal delivery of the S and R enantiomers of flurbiprofen in the formalin test. Eur. J. Pharmacol. 1994; 256: 205-9.
19. Neupert W, Brugger R, Euchenhofer C, Brune K and Geisslinger G. Effects of ibuprofen enantiomers and its coemzyme A thioesters on human prostaglandin endoperoxide synthases, Br. J. Pharmacol. 1997; 122: 487-92.
20. Neubert JK, Maidment NT, Matsuka Y, Adelson DW, Kruger L, Spiegelman I. Inflammation-induced changes in primary afferent-evoked release of substance P within trigeminal ganglia in vivo, Brain Res. 2000; 871: 181-91.
21. Peskar BM, Kluge S, Peskar BA, Soglowek SM, Brune K. Effects of pure enantiomers in comparison to racemic flurbiprofen on eicosanoid release from various rat organs ex vivo, Prostaglandins 1991; 42: 515-31.
22. Pethö G, Derow A, Reeh PW. Bradykinin-induced sensitization to heat of nociceptors depends on COX products in the isolated rat skin, Europ. J. Neurosci. 2001; 14: 210-8.
23. Sauer SK, Averbeck B and Reeh PW. Denervation and NK1 receptor block modulate stimulated CGRP and PGE2 release from rat skin, NeuroReport 2000; 11: 283-6.
24. Sauer SK, Schäfer D, Kress M and Reeh PW. Stimulated prostaglandin E2 release from rat skin, in vitro, Life Sci. 1998; 62: 2045-55.
25. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs, Nature 1971; 231: 232-5.
26. Vasko MR, Campbell WB, Waite KJ. Prostaglandin E2 enhances bradykinin-stimulated release of neuropeptides from rat sensory neurons in culture. J. Neurosci. 1994; 14: 4987-97.
27. 2 release from isolated rat dura mater, in vitro. Pain 2003; 103: 313-20.